Abstract:Introduction This review aimed to identify common pathophysiological mechanisms that exist between depression and obesity, as well as pharmacological strategies used in clinical trials and animal models. It is necessary to carry out larger studies that integrate the multiple neurobiological processes of these phenomena and the search for therapeutic targets that affect these pathways. Objectives Conduct a literature review on the common neurobiological aspects that exist between depression and obesity. Compare pharmacological and therapeutic strategies in the management of depressive patients by means of common neurobiological mechanisms. Methods We used the Pubmed search engine to search for the keywords: ((depression and obesity) OR (common pathways for depression and obesity) OR (therapeutic targets for depression and obesity) OR (neurobiology of depression and obesity) OR (treatments for depression and obesity))Once the predefined screening was carried out, 68 studies were identified. 54 articles were left for review and analysis. At the end of the review, 25 studies were discarded, including 29 studies with relevance to the objectives described in the study. These articles were selected when they provided information with adequate, concrete and specific reasoning towards the scientific and methodological elements of the review. Results Table 1: Findings related to the NEGR1 gene and its involvement in processes associated with alterations associated with depression and obesity. Table 2: Findings of inflammation associated with depression and obesity in clinical trials and animal models. Image: Image 2: Conclusions Alterations in the NEGR1 gene, inflammatory markers, HPA axis and microbiota demonstrate multiple pathophysiological mechanisms in the clinical pictures associated with obesity and depression. Infliximab, pioglitazone, ondansentron, BVT.2733 and palmitoylethanolamide showed anti-inflammatory regulatory effects with reduction in depressive symptoms and multiple anti-inflammatory markers. Animal models for obesity and depression present ample and reliable evidence regarding the use of drugs that direct their therapeutic profile towards the pathophysiological mechanisms involved in pathologies involving depressive and metabolic disorders. Disclosure of Interest None Declared

Influence of Metabolic Dysregulation in the Management of Depressive Disorder—Narrative Review

Characteristics of the Gut Microbiota in Bipolar Depressive Disorder Patients with Distinct Weight.

Depression and Obesity—Do We Know Everything about It? A Narrative Review

Factors Associated with the Development of Depression and the Influence of Obesity on Depressive Disorders: A Narrative Review

Obesity and depression: Review on common neurobiological mechanisms and identification of potential drug targets.

Psychiatric Aspects of Obesity: A Narrative Review of Pathophysiology and Psychopathology

Depression and Metabolic Syndrome: A Narrative Review

Diet, Obesity, and Depression: A Systematic Review

Adiposity in Depression or Depression in Adiposity? The Role of Immune-Inflammatory-Microbial Overlap

The Role of the Microbiome-Brain-Gut Axis in the Pathogenesis of Depressive Disorder

Exercise as medicine for depressive symptoms? A systematic review and meta-analysis with meta-regression

Microbiome and immuno-metabolic dysregulation in patients with major depressive disorder with atypical clinical presentation

The Role of Probiotics and Their Metabolites in the Treatment of Depression

The role of probiotics in the treatment of depressive disorders. A critical review

Obesity and Depression: Common Link and Possible Targets

Obesity and Depression. Some Neurochemical and Molecular Links

Healthy diet, depression and quality of life: A narrative review of biological mechanisms and primary prevention opportunities

EPIDEMIOLOGY OF DEPRESSIVE STATES IN ACUTE AND CHRONIC CONDITIONS

Role of Inflammatory Mechanisms in Major Depressive Disorder: From Etiology to Potential Pharmacological Targets

Effects and neural mechanisms of different physical activity on major depressive disorder based on cerebral multimodality monitoring: a narrative review

Mechanisms Involved in the Link between Depression, Antidepressant Treatment, and Associated Weight Change